Table 3.
Univariate logistic regression analysis of factors predicting overall survival in patients undergoing radical esophagectomy
| Variable | P value | Odds ratio | 95% CI |
|---|---|---|---|
| Pre-op Sarcopeniaa | 0.5259 | 0.60 | 0.13 - 3.19 |
| TPI reduction rate severe group | 0.0074* | 4.43 | 1.47 - 15.3 |
| Age ≥ 66 y | 0.0942 | 2.57 | 0.86 - 8.86 |
| ≥ ASA 3 | 0.0109* | 8.33 | 1.62 - 62.47 |
| Pre-op Albumin < 3.6 g/dL | 0.7550 | 1.33 | 0.17 - 7.46 |
| No preoperative therapy | 0.0492* | 3.16 | 1.00 - 10.21 |
| No postoperative therapy | 0.5367 | 0.72 | 0.25 - 2.03 |
| Pre-op BMI < 18.5 kg/m2 | 0.3262 | 0.47 | 0.07 - 2.00 |
| Open or TEPP | 0.1053 | 2.45 | 0.83 - 7.33 |
| Open or HALS | 0.2610 | 1.84 | 0.63 - 5.35 |
| LN dissection field (2-field / 3-field) | 0.5692 | 1.36 | 0.48 - 4.15 |
| Blood loss ( > 330 ml) | 0.4524 | 1.49 | 0.53 - 4.29 |
| Operation time ( > 616 min) | 1.0000 | 1.0000 | 0.35 - 2.83 |
| ≥ pStage III | 0.0012* | 6.40 | 2.02 - 24.87 |
Pre-op preoperative, TPI total psoas major muscle mass index, ASA the American Society of Anesthesia physical status, BMI Body mass index, TEPP Thoracoscopic esophagectomy in the prone position, HALS Hand-assisted laparoscopic surgery, LN lymph node, pStage pathological stage (UICC 8th), aAccording to the definition of Prado [22], *p value <0.05